stars 1 stars 2 stars 3

Abomics is a Finnish health technology company founded in 2013 by medical doctors that specializes in pharmacogenetics. We support healthcare professionals with pharmacogenetic solutions that enable precision medication. Pharmacogenetic testing helps identify more effective and safer medication and dosages, reducing trial-and-error prescribing and minimizing the risk of adverse drug reactions. Our solutions are designed to integrate seamlessly into clinical workflows bringing pharmacogenetic insights into everyday clinical decision-making. Built on scientific evidence and clinical expertise, we are a trusted partner to hospitals, laboratories, pharmaceutical companies, genomic service providers, and biobanks. Our PGx solutions: • Interpretation • Medical guidance • System integration • Medical databases • Consultation and education We work closely with each customer to deliver customisable solution that meets your needs in pharmacogenetics. Let’s take a next step in PGx together. 📩 Contact us: info@abomicspgx.com 🔗 Learn more: abomicspgx.com 📍 Based in Finland. Supporting healthcare providers globally. ✅ ISO 13485:2016 certified, ensuring safe, compliant, and high-quality pharmacogenetic services

Website https://abomicspgx.com/
Employees 19 (7 on RocketReach)
Founded 2013
Address Yliopistonkatu 31, Turku, Southwest Finland 20100, FI
Phone +358 50 3632200
Industry Hospitals and Health Care

Abomics Questions

Sami Miettinen is the CEO of Abomics.

7 people are employed at Abomics.

Abomics is based in Turku, Southwest Finland.

Top Abomics Employees

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users